Saira Khaderi
Dr. Khaderi is a member of AASLD's Women's Initiative Committee and Education Lead of the HCV SIG.
Dr. Khaderi is a member of AASLD's Women's Initiative Committee and Education Lead of the HCV SIG.
Dr. Fenkel is a Professor of Medicine at Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia, PA, USA. He is the Director of the Jefferson Viral Hepatitis Center and Associate Medical Director of Liver Transplantation at Thomas Jefferson University Hospital.
Ms. Zapatka, MSN, APN-BC is currently the VA CT Healthcare System's (VACHS) Liver Resource Center's Nurse Practitioner. Susan was the NP Co-Director for the Center of Excellence in Primary Care Education, and recipient of many nursing and academic awards, including Yale School of Medicine Internal Medicine Primary Care Residency Program – Support Staff Recognition Award and the CTAPRN NP of the Year Award.
My name is Anna Marie Hefner, PhD, RN, CPNP, FAASLD.. Her dissertation is entitled "A Descriptive Study of Nutritional Parameters in Patients with Cirrhosis. She is the Director of Nashville at a community-based liver center. We acknowledge each patient and work with the guidelines set forth with AASLD and the individual goals of the patient. We discussed their plan of action and meet them where they are at using the "HALO" approach-health and liver optimization. <br>I am a fellow of the ASSLD.
Whitney Steinmetz is a board-certified family nurse practitioner who provides patient-focused, evidence-based care in gastroenterology and hepatology. She has a passion for improving access to care in rural healthcare environments. Dr. Steinmetz earned her bachelor's of science degree with honors, Magna Cum Laude, at the University of Arizona.
Lisa Catalli is a Nurse Practitioner in the Hepatology Department at the University of California San Francisco and an assistant clinical professor at the UCSF School of Nursing. She holds a Master of Science degree and is currently pursuing a PhD at the UCSF School of Nursing. With over 15 years of experience in Hepatology, Lisa specializes in viral hepatitis and MASLD across the liver disease spectrum, including care for liver transplant recipients.
Melissa Palmer, MD has been a Hepatologist for over 35 years and is an experienced biotech/pharma executive. She is currently CEO of Liver Consulting LLC, consulting exclusively to biotech and pharmaceutical companies on hepatology-related issues such as: innovative trial designs for all liver diseases including metabolic dysfunction-associated steatotic hepatitis (MASH), Hepatitis B and D, primary sclerosing cholangitis (PSC), all aspects of liver disease drug development from pre-IND to NDA, and hepatic impairment studies.
Raúl J. Andrade is Professor of Medicine and Director of the Department of Medicine at the University of Malaga. Head of the Gastroenterology Service, University Hospital. Vice-Director of the Institute of Biomedical Research IBIMA-Plataforma BIONAND. He is the Founder and Director of the Spanish Drug Induced Liver Injury Registry (www.spanishdili.uma.es), of the Spanish Latin-American DILI Network and the Prospective European DILI Registry awarded by the EASL. Chairman of the EASL Clinical Practice Guidelines on Drug Induced Liver Injury.
Dr. Rockey is currently a Distinguished University Professor and Director of the MUSC Digestive Disease Research Center and has active research portfolio's in basic as well as clinical science. His laboratory focuses on mechanisms of liver fibrosis and has coined the field of molecular portal hypertension. He has also been actively involved in clinical research focused on liver fibrosis and portal hypertension. Dr.
Arie Regev, MD, FAASLD <br>Dr. Arie Regev is a gastroenterologist and hepatologist with more than 30 years of experience in the treatment and research of liver diseases. He is the Vice President of Medical Global Patient Safety at Eli Lilly and Company, and he heads Eli Lilly's Safety Advisory Hub. In addition, Dr. Regev is the chair of Eli Lilly's Liver Safety Committee, a role he has held for more than 15 years. <br>Dr. Regev is an associate professor of medicine at the division of gastroenterology and hepatology of Indiana University School of Medicine.